Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 17 de 17
Filtrer
1.
Vet Parasitol ; 275: 108924, 2019 Nov.
Article de Anglais | MEDLINE | ID: mdl-31630049

RÉSUMÉ

Rhabditis spp., is a nematode known to cause otitis externa, an infection difficult to control, in cattle reared within tropical regions. The objective of this study was to assess the combined use of ivermectin 1%, dimethyl sulfoxide 1% and mineral oil 100% containing nematophagous fungi of both Duddingtonia flagrans (AC001) and Monacrosporium thaumasium (NF34) species to control in vitro Rhabditis spp. Thus, 12 experimental groups were designed with eight replicates each: G1 (nematodes + AC001); G2 (nematodes + NF34); G3 (nematodes + ivermectin 1%/positive control); G4 (nematodes + dimethyl sulfoxide 1%/positive control); G5 (nematodes + mineral oil 100%/positive control); G6 (nematodes + AC001 + ivermectin 1%); G7 (nematodes + NF34 + ivermectin 1%); G8 (nematodes + AC001 + mineral oil 100%); G9 (nematodes + NF34 + mineral oil 100%); G10 (nematodes + AC001 + dimethyl sulfoxide 1%); G11 (nematode + NF34 + dimethyl sulfoxide 1%); G12 (nematode + distilled water/negative control). The results demonstrated that all experimentally treated groups differed statistically (p < 0.01) from the control group. In the present study, the use of dimethyl sulfoxide 1% and mineral oil 100% in conjunction with conidia fungi portrayed noteworthy outcomes, which represents a future premise for the combined use of nematophagous fungi within these vehicles in both controlling Rhabditis spp.


Sujet(s)
Antiparasitaires/pharmacologie , Diméthylsulfoxyde/pharmacologie , Ivermectine/pharmacologie , Huile minérale/pharmacologie , Infections à Rhabditida/médecine vétérinaire , Rhabditoidea/effets des médicaments et des substances chimiques , Animaux , Antiparasitaires/usage thérapeutique , Ascomycota/physiologie , Bovins , Maladies des bovins/traitement médicamenteux , Maladies des bovins/parasitologie , Maladies des bovins/prévention et contrôle , Industrie laitière , Diméthylsulfoxyde/usage thérapeutique , Duddingtonia/physiologie , Femelle , Ivermectine/usage thérapeutique , Mâle , Huile minérale/usage thérapeutique , Deuteromycota/physiologie , Otite externe/traitement médicamenteux , Otite externe/parasitologie , Otite externe/prévention et contrôle , Otite externe/médecine vétérinaire , Infections à Rhabditida/traitement médicamenteux , Infections à Rhabditida/microbiologie , Infections à Rhabditida/prévention et contrôle , Rhabditoidea/microbiologie
2.
Rev. bras. cir. plást ; 31(1): 136-139, jan.-mar. 2016. ilus
Article de Anglais, Portugais | LILACS | ID: biblio-1540

RÉSUMÉ

O número de frequentadores de academia que utilizam injeções de substâncias oleosas para aumentar o volume muscular artificialmente, buscando, com essa prática, uma melhora cosmética dos músculos que não responderiam aos treinamentos, vem aumentando. Apesar dos efeitos imediatos e dos bons resultados estéticos como aumento de volume ou modificação do contorno de várias áreas do corpo, a infiltração de óleo pode levar a diversas complicações a curto e longo prazo, que muitas vezes são irreversíveis. A conscientização e atuação das entidades de classes médicas e sanitárias tornam-se fundamentais na profilaxia e controle deste problema. Neste artigo revisamos as complicações e ainda relatamos o caso de um paciente com complicações locais importantes secundárias a injeção de óleo.


The number of gym goers who self-inject oily substances to increase muscle volume artificially and thereby improve the aesthetic appearance of their muscles that are unresponsive to training is increasing. Although immediate effects and satisfactory aesthetic results such as increased volume or changes in the contour of several areas of the body might be observed, oil infiltration might cause several short- and long-term complications, which are often irreversible. The awareness and actions of medical and health professional societies are fundamental for the prevention and control of this problem. In this article, possible complications are reviewed, and the case of a patient with severe local complications caused by oil injection is reported.


Sujet(s)
Humains , Mâle , Adulte , Histoire du 21ème siècle , Présentations de cas , Huile minérale , Infiltration-Percolation , Revue de la littérature , Composés Chimiques , Prévention des Maladies , Médicaments Fondés sur des Vitamines ou des Minéraux , Injections , Huile minérale/usage thérapeutique , Infiltration-Percolation/méthodes , Composés Chimiques/effets indésirables , Composés Chimiques/méthodes , Injections/instrumentation
6.
Braz Oral Res ; 25(6): 556-61, 2011.
Article de Anglais | MEDLINE | ID: mdl-22147238

RÉSUMÉ

Dental biofilm control represents a basic procedure to prevent caries and the occurrence of periodontal diseases. Currently, toothbrushes and dentifrices are used almost universally, and the employment of good oral hygiene allows for appropriate biofilm removal by both mechanical and chemical control. The aim of this study was to evaluate the effectiveness of adding vegetable or mineral oil to a commercially available dentifrice in dental biofilm control. A comparison using the Oral Hygiene Index Simplified (OHI-S) was performed in 30 individuals who were randomly divided into three groups. Group 1 (G1) received a commercially available dentifrice; the composition of this dentifrice was modified by addition of mineral oil (Nujol®) for group 2 (G2) or a vegetable oil (Alpha Care®) for group 3 (G3) at 10% of the total volume, respectively. The two-way repeated-measures analysis of variance (two-way ANOVA) was used to test the effect of group (G1, G2 and G3) or time (baseline, 45 days and 90 days) on the OHI-S index scores. Statistical analysis revealed a significant reduction in the OHI-S at day 90 in G2 (p < 0.05) and G3 (p < 0.0001) in comparison to G1. Therefore, the addition of a vegetable or a mineral oil to a commercially available dentifrice improved dental biofilm control, suggesting that these oils may aid in the prevention and/or control of caries and periodontal disease.


Sujet(s)
Biofilms/effets des médicaments et des substances chimiques , Plaque dentaire/prévention et contrôle , Dentifrices/usage thérapeutique , Huile minérale/usage thérapeutique , Noix/composition chimique , Huiles végétales/usage thérapeutique , Adolescent , Analyse de variance , Bertholletia/composition chimique , Caries dentaires/prévention et contrôle , Dentifrices/composition chimique , Femelle , Humains , Mâle , Huile minérale/composition chimique , Indice d'hygiène buccale , Maladies parodontales/prévention et contrôle , Huiles végétales/composition chimique , Facteurs temps , Résultat thérapeutique , Jeune adulte
7.
Braz. oral res ; 25(6): 556-561, Nov.-Dec. 2011. graf
Article de Anglais | LILACS | ID: lil-608026

RÉSUMÉ

Dental biofilm control represents a basic procedure to prevent caries and the occurrence of periodontal diseases. Currently, toothbrushes and dentifrices are used almost universally, and the employment of good oral hygiene allows for appropriate biofilm removal by both mechanical and chemical control. The aim of this study was to evaluate the effectiveness of adding vegetable or mineral oil to a commercially available dentifrice in dental biofilm control. A comparison using the Oral Hygiene Index Simplified (OHI-S) was performed in 30 individuals who were randomly divided into three groups. Group 1 (G1) received a commercially available dentifrice; the composition of this dentifrice was modified by addition of mineral oil (Nujol®) for group 2 (G2) or a vegetable oil (Alpha Care®) for group 3 (G3) at 10 percent of the total volume, respectively. The two-way repeated-measures analysis of variance (two-way ANOVA) was used to test the effect of group (G1, G2 and G3) or time (baseline, 45 days and 90 days) on the OHI-S index scores. Statistical analysis revealed a significant reduction in the OHI-S at day 90 in G2 (p < 0.05) and G3 (p < 0.0001) in comparison to G1. Therefore, the addition of a vegetable or a mineral oil to a commercially available dentifrice improved dental biofilm control, suggesting that these oils may aid in the prevention and/or control of caries and periodontal disease.


Sujet(s)
Adolescent , Femelle , Humains , Mâle , Jeune adulte , Biofilms/effets des médicaments et des substances chimiques , Plaque dentaire/prévention et contrôle , Dentifrices/usage thérapeutique , Huile minérale/usage thérapeutique , Noix/composition chimique , Huiles végétales/usage thérapeutique , Analyse de variance , Bertholletia/composition chimique , Caries dentaires/prévention et contrôle , Dentifrices/composition chimique , Huile minérale/composition chimique , Indice d'hygiène buccale , Maladies parodontales/prévention et contrôle , Huiles végétales/composition chimique , Facteurs temps , Résultat thérapeutique
8.
Mem. Inst. Oswaldo Cruz ; 106(8): 1052-1054, Dec. 2011. graf
Article de Anglais | LILACS, Sec. Est. Saúde SP | ID: lil-610986

RÉSUMÉ

Vaccination is the method of choice for the prevention of influenza infection. However, the quantity of the antigen available, especially in the case of pandemics, often fails to meet the global demand. However, improved adjuvants can overcome this problem. Preliminary results obtained in this study revealed that one year after a single subcutaneous immunisation with influenza A H3N2 virus in an oil-based carrier, VaxcineTM, outbreed mice produced a high immunoglobulin G response that lasted for up to one year and exhibited less variation in titre compared with the response of the control group treated with alum. The haemagglutination-inhibition titres induced by VaxcineTM were also higher than those generated by alum. These data indicate that VaxcineTM is a good adjuvant candidate for seasonal influenza vaccines.


Sujet(s)
Animaux , Femelle , Souris , Adjuvants immunologiques/usage thérapeutique , /immunologie , Vaccins antigrippaux/usage thérapeutique , Infections à Orthomyxoviridae/prévention et contrôle , Anticorps antiviraux/sang , Anticorps antiviraux/immunologie , Tests d'inhibition de l'hémagglutination , Immunoglobuline G/sang , Immunoglobuline G/immunologie , Huile minérale/usage thérapeutique , Infections à Orthomyxoviridae/immunologie
9.
Mem Inst Oswaldo Cruz ; 106(8): 1052-4, 2011 Dec.
Article de Anglais | MEDLINE | ID: mdl-22241133

RÉSUMÉ

Vaccination is the method of choice for the prevention of influenza infection. However, the quantity of the antigen available, especially in the case of pandemics, often fails to meet the global demand. However, improved adjuvants can overcome this problem. Preliminary results obtained in this study revealed that one year after a single subcutaneous immunisation with influenza A H3N2 virus in an oil-based carrier, Vaxcine(TM), outbreed mice produced a high immunoglobulin G response that lasted for up to one year and exhibited less variation in titre compared with the response of the control group treated with alum. The haemagglutination-inhibition titres induced by Vaxcine(TM) were also higher than those generated by alum. These data indicate that Vaxcine(TM) is a good adjuvant candidate for seasonal influenza vaccines.


Sujet(s)
Adjuvants immunologiques/usage thérapeutique , Sous-type H3N2 du virus de la grippe A/immunologie , Vaccins antigrippaux/usage thérapeutique , Infections à Orthomyxoviridae/prévention et contrôle , Animaux , Anticorps antiviraux/sang , Anticorps antiviraux/immunologie , Femelle , Tests d'inhibition de l'hémagglutination , Immunoglobuline G/sang , Immunoglobuline G/immunologie , Souris , Huile minérale/usage thérapeutique , Infections à Orthomyxoviridae/immunologie
11.
J Bras Pneumol ; 35(9): 839-45, 2009 Sep.
Article de Anglais, Portugais | MEDLINE | ID: mdl-19820809

RÉSUMÉ

OBJECTIVE: To present aspects of the evolution of lipoid pneumonia in children, based on clinical, radiological and bronchoalveolar lavage fluid findings, emphasizing the importance of bronchoalveolar lavage for the diagnosis and treatment. METHODS: We included 28 children, with a mean age of 20 months (range, 1-108 months), diagnosed with chronic pneumonia refractory to antimicrobial therapy, with TB or with a combination of the two. Most of the children had at least one risk factor for aspiration, and all of them had a history of mineral oil ingestion for intestinal constipation (23/28) or complicated ascaridiasis (5/28). Clinical evaluations, tomographic evaluations and analyses of bronchoalveolar lavage fluid were carried out at the beginning of treatment and throughout a follow-up period of 24 months. RESULTS: Tachypnea and cough were the most common symptoms. The most common radiological alterations were areas of consolidation (23/28), perihilar infiltrates (13/28) and hyperinflation (11/28). Chest CT scans showed areas of consolidation with air bronchogram (24/28), decreased attenuation in the areas of consolidation (16/28), ground-glass opacities (3/28) and crazy-paving pattern (1/28). In the analysis of the bronchoalveolar lavage fluid, Sudan staining revealed foamy macrophages, confirming the diagnosis of lipoid pneumonia. After treatment with multiple bronchoalveolar lavages (mean = 9.6), 20 children became asymptomatic, 18 of those presenting normal tomographic images. CONCLUSIONS: A diagnosis of lipoid pneumonia should be considered in patients with chronic refractory pneumonia or TB, especially if there is a history of mineral oil ingestion. Bronchoscopy with multiple bronchoalveolar lavages was an efficient treatment for the clearance of mineral oil from the lung parenchyma and the prevention of fibrosis. This strategy contributed to reducing the morbidity of lipoid pneumonia, which remains a rare diagnosis.


Sujet(s)
Lavage bronchoalvéolaire/méthodes , Stéatose pulmonaire , Lavage bronchoalvéolaire/normes , Enfant , Enfant d'âge préscolaire , Constipation/traitement médicamenteux , Diagnostic différentiel , Femelle , Humains , Nourrisson , Mâle , Huile minérale/effets indésirables , Huile minérale/usage thérapeutique , Stéatose pulmonaire/induit chimiquement , Stéatose pulmonaire/diagnostic , Stéatose pulmonaire/thérapie , Tomodensitométrie , Tuberculose pulmonaire/diagnostic
12.
J. bras. pneumol ; J. bras. pneumol;35(9): 839-845, set. 2009. ilus, tab
Article de Portugais | LILACS | ID: lil-528388

RÉSUMÉ

OBJETIVO: Descrever os aspectos da evolução da pneumonia lipoide em crianças, com base em aspectos clínicos, radiológicos e de achados no lavado broncoalveolar, enfatizando a importância diagnóstica e terapêutica da lavagem broncoalveolar. MÉTODOS: Foram incluídas 28 crianças, com idade média de 20 meses (1-108 meses) e diagnóstico de pneumonia crônica refratária a antimicrobianos e/ou TB. A maioria apresentava um fator de risco para aspiração, e todas apresentavam história de ingestão de óleo mineral para o tratamento de constipação intestinal (23/28) ou de ascaridíase complicada (5/28). A avaliação clínica e tomográfica e análises do lavado broncoalveolar foram realizadas no início do tratamento e em até 24 meses. RESULTADOS: Os sintomas mais frequentes foram taquipneia e tosse. As principais alterações radiológicas foram consolidações (23/28), infiltrado peri-hilar (13/28) e hiperinsuflação (11/28). A TC de tórax mostrou consolidações com broncograma aéreo (24/28), diminuição de atenuação nas áreas de consolidação (16/28), opacidade em vidro fosco (3/28) e padrão em mosaico (1/28). O estudo do lavado broncoalveolar apresentava macrófagos espumosos corados por Sudan, confirmando o diagnóstico da pneumonia lipoide. Após tratamento com múltiplas lavagens broncoalveolares (média = 9,6), 20 crianças tornaram-se assintomáticas, havendo normalização tomográfica em 18. CONCLUSÕES: O diagnóstico de pneumonia lipoide deve ser considerado na pneumonia crônica ou TB refratárias ao tratamento, especialmente se houver história de ingestão de óleo mineral. A broncoscopia com múltiplas lavagens broncoalveolares mostrou-se eficiente para a depuração do óleo aspirado do parênquima pulmonar e a prevenção da fibrose, contribuindo para a redução da morbidade dessa doença, que ainda é pouco diagnosticada.


OBJECTIVE: To present aspects of the evolution of lipoid pneumonia in children, based on clinical, radiological and bronchoalveolar lavage fluid findings, emphasizing the importance of bronchoalveolar lavage for the diagnosis and treatment. METHODS: We included 28 children, with a mean age of 20 months (range, 1-108 months), diagnosed with chronic pneumonia refractory to antimicrobial therapy, with TB or with a combination of the two. Most of the children had at least one risk factor for aspiration, and all of them had a history of mineral oil ingestion for intestinal constipation (23/28) or complicated ascaridiasis (5/28). Clinical evaluations, tomographic evaluations and analyses of bronchoalveolar lavage fluid were carried out at the beginning of treatment and throughout a follow-up period of 24 months. RESULTS: Tachypnea and cough were the most common symptoms. The most common radiological alterations were areas of consolidation (23/28), perihilar infiltrates (13/28) and hyperinflation (11/28). Chest CT scans showed areas of consolidation with air bronchogram (24/28), decreased attenuation in the areas of consolidation (16/28), ground-glass opacities (3/28) and crazy-paving pattern (1/28). In the analysis of the bronchoalveolar lavage fluid, Sudan staining revealed foamy macrophages, confirming the diagnosis of lipoid pneumonia. After treatment with multiple bronchoalveolar lavages (mean = 9.6), 20 children became asymptomatic, 18 of those presenting normal tomographic images. CONCLUSIONS: A diagnosis of lipoid pneumonia should be considered in patients with chronic refractory pneumonia or TB, especially if there is a history of mineral oil ingestion. Bronchoscopy with multiple bronchoalveolar lavages was an efficient treatment for the clearance of mineral oil from the lung parenchyma and the prevention of fibrosis. This strategy contributed to reducing the morbidity of lipoid pneumonia, which remains a rare diagnosis.


Sujet(s)
Enfant , Enfant d'âge préscolaire , Femelle , Humains , Nourrisson , Mâle , Lavage bronchoalvéolaire/méthodes , Stéatose pulmonaire , Lavage bronchoalvéolaire/normes , Constipation/traitement médicamenteux , Diagnostic différentiel , Huile minérale/effets indésirables , Huile minérale/usage thérapeutique , Stéatose pulmonaire/induit chimiquement , Stéatose pulmonaire/diagnostic , Stéatose pulmonaire/thérapie , Tomodensitométrie , Tuberculose pulmonaire/diagnostic
13.
J Pediatr (Rio J) ; 85(4): 322-8, 2009.
Article de Anglais, Portugais | MEDLINE | ID: mdl-19668908

RÉSUMÉ

OBJECTIVE: To evaluate the effects of conventional treatment of chronic functional constipation on total and segmental colonic transit times and on orocecal transit time. METHODS: A total of 34 consecutive patients with functional constipation attending a specialized outpatient clinic were included in the study. Total and segmental colonic transit times were assessed using radiopaque markers. Hydrogen breath test was used to evaluate lactulose and bean orocecal transit times. Treatment consisted of disimpaction, general and dietary fiber intake instruction, and mineral oil administration. RESULTS: At admission, colonic dysmotility was found in 71.9% (23/32) of patients. All patients who complied with the treatment showed improvement of clinical symptoms after 6 weeks of treatment, when 82.6% (19/23) of those with dysmotility at admission returned to normal or reduced the severity of colonic transit patterns. Transit time decreased (medians) between admission and eighth week of treatment: lactulose orocecal transit (from 70 to 50 minutes, p = 0.002), bean orocecal transit (from 240 to 220 minutes, p = 0.002), and total colonic transit (from 69.5 to 37.0 hours, p = 0.001). The need for mineral oil therapy for constipation after a 12-month treatment was associated with persistence of total colonic transit higher than 62 hours at the eighth week of treatment (p = 0.014). CONCLUSION: The conventional therapeutic approach yielded good results regardless of the presence or not of colonic dysmotility at inclusion in the study. Digestive tract motility abnormalities in functionally constipated children may be reversed, and may be secondary to constipation.


Sujet(s)
Constipation/thérapie , Transit gastrointestinal/physiologie , Adolescent , Enfant , Enfant d'âge préscolaire , Maladie chronique , Défécographie/méthodes , Fibre alimentaire/usage thérapeutique , Fabaceae/métabolisme , Femelle , Motilité gastrointestinale/effets des médicaments et des substances chimiques , Motilité gastrointestinale/physiologie , Transit gastrointestinal/effets des médicaments et des substances chimiques , Humains , Lactulose/métabolisme , Mâle , Huile minérale/usage thérapeutique , Études prospectives , Statistique non paramétrique , Facteurs temps
14.
J. pediatr. (Rio J.) ; J. pediatr. (Rio J.);85(4): 322-328, ago. 2009. tab
Article de Portugais | LILACS | ID: lil-525165

RÉSUMÉ

OBJETIVO: Avaliar o efeito do tratamento convencional da constipação crônica funcional no tempo de trânsito colônico total e segmentar e no tempo de trânsito orocecal. MÉTODOS: Foram incluídos 34 pacientes com constipação funcional atendidos consecutivamente em ambulatório especializado. O tempo de trânsito colônico total e segmentar foi avaliado com marcadores radiopacos. O tempo de trânsito orocecal da lactulose e do feijão foi avaliado com teste do hidrogênio no ar expirado. O tratamento constou de desimpactação, orientações gerais e de consumo de dieta rica em fibra alimentar e administração de óleo mineral. RESULTADOS: Na admissão, dismotilidade colônica foi encontrada em 71,9 por cento (23/32) dos pacientes. Todos os pacientes que realizaram corretamente o tratamento apresentaram melhora clínica na sexta semana do tratamento quando 82,6 por cento (19/23) daqueles com dismotilidade na admissão apresentaram normalização ou diminuição da gravidade no padrão de trânsito colônico. Observou-se redução do tempo de trânsito (medianas) entre a admissão e a oitava semana de tratamento: trânsito orocecal da lactulose (de 70 para 50 minutos, p = 0,002), orocecal do feijão (de 240 para 220 minutos, p = 0,002) e colônico total (de 69,5 para 37,0 horas, p = 0,001). A necessidade de uso de óleo mineral para controle da constipação aos 12 meses de tratamento associou-se com persistência de trânsito colônico total superior a 62 horas na oitava semana de tratamento (p = 0,014). CONCLUSÃO: O programa terapêutico convencional proporcionou bons resultados independentemente da presença ou não de dismotilidade colônica na admissão ao estudo. As anormalidades da motilidade digestiva na constipação funcional da criança podem apresentar reversibilidade e ser de natureza secundária.


OBJECTIVE: To evaluate the effects of conventional treatment of chronic functional constipation on total and segmental colonic transit times and on orocecal transit time. METHODS: A total of 34 consecutive patients with functional constipation attending a specialized outpatient clinic were included in the study. Total and segmental colonic transit times were assessed using radiopaque markers. Hydrogen breath test was used to evaluate lactulose and bean orocecal transit times. Treatment consisted of disimpaction, general and dietary fiber intake instruction, and mineral oil administration. RESULTS: At admission, colonic dysmotility was found in 71.9 percent (23/32) of patients. All patients who complied with the treatment showed improvement of clinical symptoms after 6 weeks of treatment, when 82.6 percent (19/23) of those with dysmotility at admission returned to normal or reduced the severity of colonic transit patterns. Transit time decreased (medians) between admission and eighth week of treatment: lactulose orocecal transit (from 70 to 50 minutes, p = 0.002), bean orocecal transit (from 240 to 220 minutes, p = 0.002), and total colonic transit (from 69.5 to 37.0 hours, p = 0.001). The need for mineral oil therapy for constipation after a 12-month treatment was associated with persistence of total colonic transit higher than 62 hours at the eighth week of treatment (p = 0.014). CONCLUSION: The conventional therapeutic approach yielded good results regardless of the presence or not of colonic dysmotility at inclusion in the study. Digestive tract motility abnormalities in functionally constipated children may be reversed, and may be secondary to constipation.


Sujet(s)
Adolescent , Enfant , Enfant d'âge préscolaire , Femelle , Humains , Mâle , Constipation/thérapie , Transit gastrointestinal/physiologie , Maladie chronique , Défécographie/méthodes , Fibre alimentaire/usage thérapeutique , Fabaceae/métabolisme , Motilité gastrointestinale/effets des médicaments et des substances chimiques , Motilité gastrointestinale/physiologie , Transit gastrointestinal/effets des médicaments et des substances chimiques , Lactulose/métabolisme , Huile minérale/usage thérapeutique , Études prospectives , Statistique non paramétrique , Facteurs temps
15.
J Affect Disord ; 111(2-3): 351-9, 2008 Dec.
Article de Anglais | MEDLINE | ID: mdl-18485485

RÉSUMÉ

BACKGROUND: Effect of fish oil supplementation in parkinsonian patients with depression measured by Montgomery-Asberg Rating Scale (MADRS), the Clinical Global Impressions Scale (CGI) and Beck Depression Inventory (BECK). METHOD: Double-blind, placebo-controlled study analyzed depression in 31 patients with Parkinson's Disease and Major Depression (DSM-IV). The patients were double-blind separated in 2 groups that received fish oil (containing omega-3 fatty acids) or mineral oil capsules for 3 months; each group was separated in 2 new groups: one taking antidepressant medication and another one not taking it. RESULTS: 29 patients completed the 12-week trial, 58% were female and the mean age was 64.4 years old. Patients supplemented with fish oil showed a significant decrease in MADRS and CGI-Depression scores, and there was no difference among groups in BDI. 14 patients (42%) met criteria for > or = 50% reduction in MADRS score, 7 patients (22%) met criteria for remission (final MADRS total score < or = 12), and 2 patients (6%) discontinued supplementation of fish oil. HPLC analysis of fatty-acid profile showed increase of omega-3 fatty acid in the erythrocyte membrane of patients taking fish oil. CONCLUSION: These results reveal that PD patients taking fish oil, with or without antidepressants, presented improvement in depressive symptoms and indicate that the intake of omega-3 can be used with an antidepressant effect or as adjuvant therapy with some other medication. This is a first pilot study with parkinsonian patients and omega-3 supplementation and requires replication in a larger sample.


Sujet(s)
Antidépresseurs/usage thérapeutique , Trouble dépressif majeur/traitement médicamenteux , Acides gras omega-3/usage thérapeutique , Maladie de Parkinson/épidémiologie , Maladie de Parkinson/psychologie , Sujet âgé , Antiparkinsoniens/usage thérapeutique , Brésil/épidémiologie , Association thérapeutique , Comorbidité , Trouble dépressif majeur/diétothérapie , Trouble dépressif majeur/épidémiologie , Compléments alimentaires , Méthode en double aveugle , Acides gras omega-3/administration et posologie , Femelle , Humains , Lévodopa/usage thérapeutique , Mâle , Adulte d'âge moyen , Huile minérale/usage thérapeutique , Maladie de Parkinson/traitement médicamenteux , Inventaire de personnalité , Projets pilotes , Placebo , Échelles d'évaluation en psychiatrie/statistiques et données numériques , Résultat thérapeutique
16.
Pediatr Radiol ; 37(11): 1135-9, 2007 Nov.
Article de Anglais | MEDLINE | ID: mdl-17876572

RÉSUMÉ

BACKGROUND: Exogenous lipoid pneumonia is a rare disorder caused by aspiration of mineral, vegetable and animal oils. High-resolution CT findings of lipoid pneumonia in children taking mineral oil for constipation have been rarely reported. OBJECTIVE: To evaluate the high-resolution CT findings in 17 children with exogenous lipoid pneumonia following aspiration of mineral oil. MATERIALS AND METHODS: The study included nine boys and eight girls, with ages ranging from 2 months to 9 years. All patients underwent high-resolution CT and the images were reviewed by two radiologists who reached decisions by consensus. The inclusion criteria were an abnormal radiograph, history of taking mineral oil and the presence of intrapulmonary lipids proved by bronchoalveolar lavage or open lung biopsy. RESULTS: The most common symptoms were cough (n = 13), mild fever (n = 11), and progressive dyspnea (n = 9). The main CT findings were air-space consolidations (100%), usually with areas of fatty attenuation (70.6%), areas of ground-glass attenuation (52.9%), and a crazy-paving pattern (17.6%), predominating bilaterally in the posterior and lower regions of the lungs. CONCLUSION: The high-resolution CT features in children with exogenous lipoid pneumonia are air-space consolidations and ground-glass attenuation, occasionally with a crazy-paving pattern, distributed bilaterally in the posterior and lower zones of the lungs.


Sujet(s)
Constipation/thérapie , Huile minérale/effets indésirables , Huile minérale/usage thérapeutique , Stéatose pulmonaire/induit chimiquement , Stéatose pulmonaire/imagerie diagnostique , Tomodensitométrie/méthodes , Enfant , Enfant d'âge préscolaire , Constipation/imagerie diagnostique , Femelle , Humains , Nourrisson , Mâle , Études rétrospectives
17.
Clin Exp Dermatol ; 17(3): 159-62, 1992 May.
Article de Anglais | MEDLINE | ID: mdl-1451289

RÉSUMÉ

Omega-3 polyunsaturated fatty acids compete with arachidonic acid as substrates for lipoperoxidases, which transform them into leukotrienes with low biological activity. As this process, in skin, may benefit psoriatic patients, a randomized controlled single blind-study was carried out on a sample of 25 patients. In the study fish oil (FO) was compared with liquid paraffin (LP); both were topically applied and administered daily for 6 h under an occlusive dressing over a 4-week period. Evaluations were performed weekly assessing erythema, scaling, plaque thickness (induration) and itching. The results showed statistically significant improvement in erythema and scaling for both treatments compared to basal values; significant differences between treatments were achieved in scaling but not in erythema. Compared to baseline, FO significantly improved plaque thickness while LP did not. After 4 weeks, FO proved to be significantly better than LP. All patients accepted the treatment despite its unpleasant smell. Irritation and a burning sensation were reported in the FO treated plaque of one patient. This adverse effect reverted after completing the treatment. These findings demonstrate that topical FO shows a better performance than LP under an occlusive dressing.


Sujet(s)
Huiles de poisson/usage thérapeutique , Psoriasis/traitement médicamenteux , Administration par voie topique , Adolescent , Adulte , Sujet âgé , Femelle , Humains , Mâle , Adulte d'âge moyen , Huile minérale/usage thérapeutique , Études prospectives , Méthode en simple aveugle
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE